Just months after cutting 23% of its workforce, Viracta Therapeutics let go of 42% of employees as it increased focus on lead product candidate nana-val in lymphoma patients. The Cardiff, California, biotech announced the latest layoffs Nov. 6. An... — read more
Viracta is cutting quarter of jobs
Viracta Therapeutics is laying off 23% of its employees, the company announced Wednesday in a press release. The clinical-stage precision oncology company previously noted the layoff in a July 29 Securities and Exchange Commission filing, stating the... — read more